DiaMedica to issue 4.72M shares at $2.50 per share in private placement
PremiumThe FlyDiaMedica to issue 4.72M shares at $2.50 per share in private placement
3M ago
DiaMedica Therapeutics to expand DM199 clinical development program
Premium
The Fly
DiaMedica Therapeutics to expand DM199 clinical development program
3M ago
Diamedica Therapeutics Files SEC Report
Premium
Company Announcements
Diamedica Therapeutics Files SEC Report
4M ago
Diamedica Therapeutics Updates SEC Filing
PremiumCompany AnnouncementsDiamedica Therapeutics Updates SEC Filing
5M ago
DiaMedica Therapeutics files $100M mixed securities shelf
Premium
The Fly
DiaMedica Therapeutics files $100M mixed securities shelf
6M ago
DiaMedica Therapeutics price target lowered to $8 from $11 at Craig-Hallum
Premium
The Fly
DiaMedica Therapeutics price target lowered to $8 from $11 at Craig-Hallum
6M ago
DiaMedica appoints Ambarish Shah, Ph.D. as Chief Technology Officer
PremiumThe FlyDiaMedica appoints Ambarish Shah, Ph.D. as Chief Technology Officer
1y ago
DiaMedica Therapeutics reports Q2 EPS (16c), consensus (18c)
Premium
The Fly
DiaMedica Therapeutics reports Q2 EPS (16c), consensus (18c)
1y ago
DMAC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
DMAC Earnings this Week: How Will it Perform?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100